How to Acetylcholine?

Products for topical application comprising lysophospholipids and fatty acids,Oral Antagonist Compositions For Nicotine Burning Relief

Patents

Literature

Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.

Hiro

2 results about "Acetylcholine" patented technology

Filter

Efficacy Topic

Property

Owner

Technical Advancement

Application Domain

Technology Topic

Technology Field Word

Patent Country/Region

Patent Type

Patent Status

Application Year

Inventor

Acetylcholine (ACh) is an organic chemical that functions in the brain and body of many types of animals, and humans, as a neurotransmitter—a chemical message released by nerve cells to send signals to other cells, such as neurons, muscle cells, and gland cells. Its name is derived from its chemical structure: it is an ester of acetic acid and choline. Parts in the body that use or are affected by acetylcholine are referred to as cholinergic. Substances that interfere with acetylcholine activity are called anticholinergics.

Products for topical application comprising lysophospholipids and fatty acids

InactiveUS20070036737A1Effectively lower the smellingGood curative effectOrganic active ingredientsCosmetic preparationsWrinkle skinContinuous use

Described is a product containing at least one lysophospholipid and at least one fatty acid, as a combined preparation for simultaneous, separate or sequential use, to be topically applied, in order to temporarily and reversibly inhibit a neuromuscular junction or the release of acetylcholine from autonomic nerve endings; this product can be used for treating hyperhidrosis conditions and for the cosmetic treatment of facial and other body wrinkles and, in general, human syndromes caused by the hyperactivity of peripheral nerve terminals.

Owner:CESARE MONTECUCCO

Oral Antagonist Compositions For Nicotine Burning Relief

PendingUS20220087997A1Reduce peak perceived nicotine irritationHigh peak antagonist perceptionHydroxy compound active ingredientsInorganic non-active ingredientsGastrointestinesActivating receptors

The invention relates to oral analgesic compositions for alleviation of perceived nicotine irritation through inhibition or blocking of nicotine activated receptors or ion channels in the gastrointestinal tract, including the oral cavity. The composition of the invention comprises one or more nicotine sources, one or more buffering agents, and at least two antagonists in an effective amount to inhibit or block nicotine agonist activation of Nicotinic Acetylcholine Receptors (nAChR) and/or Transient Receptor Potential (TRP) ion channels, the at least two antagonists being selected from the group consisting of a first antagonist comprising camphor or one or more compounds resembling camphor, a second antagonist comprising eucalyptol, and a third antagonist comprising (1R,2S,5R)—N-(4-Methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide (WS-12).

Oral Antagonist Compositions For Nicotine Burning Relief

View all

Owner:FERTIN PHARMA AS

2 results about "Acetylcholine" patented technology

Products for topical application comprising lysophospholipids and fatty acids

Oral Antagonist Compositions For Nicotine Burning Relief

Popular searches